Airway Smooth Muscle Hypertrophy and Hyperplasia in Asthma
Carregando...
Citações na Scopus
234
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER THORACIC SOC
Autores
JAMES, Alan L.
ELLIOT, John G.
JONES, Robyn L.
CARROLL, Mark L.
BAI, Tony R.
ABRAMSON, Michael J.
MCKAY, Karen O.
GREEN, Francis H.
Citação
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, v.185, n.10, p.1058-1064, 2012
Resumo
Rationale: Increased thickness of the airway smooth muscle (ASM) layer in asthma may result from hyperplasia or hypertrophy of muscle cells or increased extracellular matrix (ECM). Objectives: To relate ASM hypertrophy, ASM hyperplasia, and deposition of ECM to the severity and duration of asthma. Methods: Airways from control subjects (n = 51) and from cases of nonfatal (n = 49) and fatal (n = 55) asthma were examined postmortem. Mean ASM cell volume (V-c), the number of ASM cells per length of airway (N-L), and the volume fraction of extracellular matrix (f(ECM)) within the ASM layer were estimated. Comparisons between subject groups were made on the basis of general linear regression models. Measurements and Main Results: Mean Vc was increased in the large airways of cases of nonfatal asthma (P = 0.015) and fatal asthma (P < 0.001) compared with control subjects. N-L was similar in nonfatal cases and control subjects but increased in large (P < 0.001), medium (P < 0.001), and small (P = 0.034) airways of cases of fatal asthma compared with control subjects and with nonfatal cases (large and medium airways, P <= 0.003). The f(ECM) was similar in cases of asthma and control subjects. Duration of asthma was associated with a small increase in N-L. Conclusions: Hypertrophy of ASM cells occurs in the large airways in both nonfatal and fatal cases of asthma, but hyperplasia of ASM cells is present in the large and small airways in fatal asthma cases only. Both are associated with an absolute increase in ECM. Duration of asthma has little or no effect on ASM hypertrophy or hyperplasia or f(ECM).
Palavras-chave
nonfatal asthma, extracellular matrix, asthma duration
Referências
- Abramson MJ, 2001, AM J RESP CRIT CARE, V163, P12
- Badri Kameswara Rao, 2008, Proc Am Thorac Soc, V5, P4, DOI 10.1513/pats.200704-049VS
- Bai TR, 2000, AM J RESP CRIT CARE, V162, P663
- BAI TR, 1991, AM REV RESPIR DIS, V143, P441
- Benayoun L, 2001, AM J RESP CRIT CARE, V164, P1487
- Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC
- Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS
- Bentley JK, 2009, AM J PHYSIOL-LUNG C, V296, pL176, DOI 10.1152/ajplung.90376.2008
- Black JL, 2001, AM J RESP CRIT CARE, V164, pS63
- CARROLL N, 1993, AM REV RESPIR DIS, V147, P405
- Dekkers Bart G J, 2009, Proc Am Thorac Soc, V6, P683, DOI 10.1513/pats.200907-056DP
- DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27
- EBINA M, 1990, AM REV RESPIR DIS, V141, P1327
- EBINA M, 1993, AM REV RESPIR DIS, V148, P720
- Goldsmith AM, 2006, AM J RESP CELL MOL, V34, P247, DOI 10.1165/rcmb.2005-0166OC
- Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350
- Green FHY, 2010, THORAX, V65, P32, DOI 10.1136/thx.2008.111435
- Hassan M, 2010, J ALLERGY CLIN IMMUN, V125, P1037, DOI 10.1016/j.jaci.2010.02.031
- Hassan M, 2010, J ALLERGY CLIN IMMUN, V125, pe1033
- HEARD BE, 1973, J PATHOL, V110, P319, DOI 10.1002/path.1711100406
- Holt PG, 2011, CHEST, V139, P1165, DOI 10.1378/chest.10-2397
- Huber HL, 1922, ARCH INTERN MED, V30, P689
- James AL, 2009, EUR RESPIR J, V34, P1040, DOI 10.1183/09031936.00181608
- JAMES AL, 1989, AM REV RESPIR DIS, V139, P242
- James AL, 2008, J APPL PHYSIOL, V104, P1703, DOI 10.1152/japplphysiol.00169.2008
- James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC
- JAMES AL, 1988, AM REV RESPIR DIS, V138, P136
- Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474
- Knight DA, 2004, CURR OPIN PHARMACOL, V4, P251, DOI 10.1016/j.coph.2004.02.002
- KUWANO K, 1993, AM REV RESPIR DIS, V148, P1220
- Ma XF, 1998, AM J PHYSIOL-CELL PH, V274, pC1206
- Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x
- Mauad T, 2004, AM J RESP CRIT CARE, V170, P857, DOI 10.1164/rccm.200403-305OC
- McKay KO, 2002, MED J AUSTRALIA, V177, pS45
- McParland BE, 2003, J APPL PHYSIOL, V95, P426, DOI 10.1152/japplphysiol.00159.2003
- MORENO RH, 1986, AM REV RESPIR DIS, V133, P1171
- Oliver MN, 2007, AM J RESP CELL MOL, V37, P264, DOI 10.1165/rcmb.2006-04180C
- Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2001.120951
- Pohunek P, 2005, PEDIAT ALLERG IMM-UK, V16, P43, DOI 10.1111/j.1399-3038.2005.00239.x
- Regamey N, 2008, AM J RESP CRIT CARE, V177, P837, DOI 10.1164/rccm.200707-977OC
- Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC
- Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363
- Sparrow MP, 2003, RESP PHYSIOL NEUROBI, V137, P361, DOI 10.1016/S1569-9048(03)00159-9
- STERIO DC, 1984, J MICROSC-OXFORD, V134, P127
- TAKIZAWA T, 1971, AM REV RESPIR DIS, V104, P331
- Tillie-Leblond I, 2008, ALLERGY, V63, P533, DOI 10.1111/j.1398-9995.2008.01656.x
- Tough SC, 1996, J ASTHMA, V33, P179, DOI 10.3109/02770909609054550
- Ward JE, 2008, EUR RESPIR J, V32, P362, DOI [10.1183/09031936.00119307, 10.1183/0903193.00119307]
- Woodruff PG, 2004, AM J RESP CRIT CARE, V169, P1001, DOI 10.1164/rccm.200311-1529OC
- Xu KF, 2002, J APPL PHYSIOL, V93, P1833, DOI 10.1152/japplphysiol.00738.2001
- Zhou LM, 2004, AM J RESP CRIT CARE, V169, P703, DOI 10.1164/rccm.200307-964OC